ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Researchers attack Mekong malaria superbug on multiple fronts

Fears grow that drug-resistant strains will jump from Southeast Asia to Africa

Blood samples from patients in MORU's malaria studies ready for analysis. (Photo by Gerhard Jörén (c) 2017 Mahidol-Oxford Tropical Medicine Research Unit.

BANGKOK -- Medical researchers are inching their way across the fringes of five Southeast Asian countries to test a triple combination therapy of antimalarial drugs. Results from the trial, being conducted in rural corners of Cambodia, Laos, Myanmar, Thailand and Vietnam, are due by mid-2018, according to the Mahidol Oxford Tropical Medicine Research Unit (MORU), the Bangkok-based group conducting the tests.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more